{"id":"W4408375998","doi":"10.1177/1759720x251324429","title":"Tofacitinib in early active axial spondyloarthritis: protocol of a randomized double-blind, placebo-controlled, multicenter phase IV study, FASTLANE","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Musculoskeletal Disease","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tofacitinib; Placebo; Internal medicine; Clinical endpoint; Janus kinase inhibitor; Ankylosing spondylitis; Randomized controlled trial; Clinical trial; Rheumatoid arthritis; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01759175,0.005657896,0.00842337,0.0015965,0.002991344,0.002802526,0.004204405,0.006626128,0.03814355],"category_scores_gemma":[0.01082618,0.002818827,0.002885483,0.001919765,0.003763969,0.002646443,0.001217757,0.007070692,0.008493202],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002434658,"about_ca_system_score_gemma":0.01164648,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001645618,"about_ca_topic_score_gemma":0.003317929,"domain_scores_codex":[0.9919777,0.004641672,0.0005350342,0.0009621698,0.0008554623,0.001028007],"domain_scores_gemma":[0.9939526,0.0008308162,0.001130869,0.0007948658,0.001358211,0.00193266],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9493685,0.02866344,0.0005796448,0.001950261,0.0004169792,0.00008646191,0.0001153468,0.0006293283,0.002908284,0.0006044036,0.005763204,0.008914052],"study_design_scores_gemma":[0.9672083,0.02651001,0.000684996,0.0001208122,0.0001718904,0.00002615768,0.00002193202,0.0002804365,0.0002906885,0.000266644,0.004392375,0.00002587197],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.02638715,0.0006550192,0.00231087,0.0006292551,0.0007301667,0.9639999,0.003014124,0.0002204213,0.002052969],"genre_scores_gemma":[0.02839626,0.0007998209,0.004773367,0.001261006,0.0004147648,0.9601254,0.001593572,0.00002921806,0.002606564],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.03814355,"threshold_uncertainty_score":0.1276029,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01626708598617832,"score_gpt":0.372819733988641,"score_spread":0.3565526480024627,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}